XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Beginning Balance at Dec. 31, 2022 $ 292,338 $ 4 $ 530,448 $ (238,114)  
Beginning Balance, shares at Dec. 31, 2022   42,954,820      
Issuance of common stock upon exercise of stock options 4   4    
Issuance of common stock upon exercise of stock options, shares   946      
Issuance of common stock upon vesting of restricted stock   194,455      
Shares withheld for taxes   (86,145)      
Shares withheld for taxes, Value (150)   (150)    
Purchase of common stock under Employee Stock Purchase Plan 382   382    
Purchase of common stock under Employee Stock Purchase Plan, shares   206,310      
Stock-based compensation expense 20,259   20,259    
Net Income (Loss) (142,658)     (142,658)  
Ending Balance at Dec. 31, 2023 170,175 $ 4 550,943 (380,772)  
Ending Balance, shares at Dec. 31, 2023   43,270,386      
Issuance of common stock upon exercise of stock options $ 195   195    
Issuance of common stock upon exercise of stock options, shares 92,283 92,283      
Issuance of common stock upon vesting of restricted stock   184,380      
Shares withheld for taxes   (67,813)      
Shares withheld for taxes, Value $ (141)   (141)    
Purchase of common stock under Employee Stock Purchase Plan 335   335    
Purchase of common stock under Employee Stock Purchase Plan, shares   360,265      
Issuance of common stock and pre-funded warrants pursuant to underwritten public offering, net of issuance costs of $6.3 million, Shares   32,379,667      
Issuance of common stock and pre-funded warrants pursuant to underwritten public offering, net of issuance costs of $6.3 million 91,652 $ 3 91,649    
Issuance of common stock pursuant to at-the-market offering, net of issuance costs of $1.6 million,shares   6,350,000      
issuance of common stock pursuant to at-the-market offering, net of issuance costs of $1.6 million,value 19,266 $ 1 19,265    
Stock-based compensation expense 22,233   22,233    
Other comprehensive income 16       $ 16
Net Income (Loss) (117,122)     (117,122)  
Other comprehensive loss 16       16
Ending Balance at Dec. 31, 2024 $ 186,609 $ 8 $ 684,479 $ (497,894) $ 16
Ending Balance, shares at Dec. 31, 2024   82,569,168